Every lot is tried & tested in a relevant biological assay.
Our Bioassay
- Donevan, S.D. et al. (1998) J. Pharmacol. Exp. Ther. 285, 539.
- Traynelis, S.F. et al. (2010) Pharmacol. Rev. 62, 405.
- Armstrong, N. and Gouaux, E. (2000) Neuron 28, 165.
- Kim, S. et al. (2017) Exp. Neurobiol. 26, 266.
- Foster, J.A. et al. (2003) J. Chem. Neuroanat. 26, 65.
- Kim, S. et al. (2017) Exp. Neurobiol. 26, 266.
- Wang, Y. et al. (2008) Autophagy 4, 214.
- Foster, J.A. et al. (2003) J. Chem. Neuroanat. 26, 65.
- Orav, E. et al. (2017) eNeuro 4, e0048.
Kainic acid is an analog of the excitotoxic neurotransmitter glutamate used as a selective agonist of Kainate receptors1,2.
Studies show that treatment with Kainic acid may induce seizures leading to neuronal death and biochemical changes similar to those seen in human patients with temporal lobe epilepsy1. Kainic acid may induce apoptotic death of rat striatal neurons in an autophagic mechanism2. Several studies of rat model show progressive death of nigral neurons following unilateral injection of Kainic acid in the striatum3.
Kainate-type glutamate receptors (KARs) are highly expressed in the developing brain, where they are tonically activated to modulate synaptic transmission, network excitability and synaptogenesis4.
Kainic acid monohydrate (#K-200) is a highly pure, synthetic, and biologically active compound.
Applications
Citations
Specifications
Scientific Background
Related Products
Antibodies
Pharmacological tools
Need Help With This Product?
Our reagent specialists are here to help you find the best product for your application. Please call or email us and we will be happy to help you find the right product for the job.
Call us at
+972 2587 2202 or Email Us